Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215403) titled 'Prescriptive Infusion Algorithm (PIA)' on Sept. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: AskBio Inc

Condition: PARKINSON DISEASE (Disorder)

Intervention: Procedure: Prescriptive Infusion Algorithm

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: May 1, 2026

Target Sample Size: 12

To know more, visit https://clinicaltrials.gov/study/NCT07215403

Published by HT Digital Content Services with permission from Health Daily Digest....